duocarmycin b2 has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, A; Gomi, K; Kanda, Y; Kobayashi, E; Nagamura, S; Saito, H | 1 |
| Amishiro, N; Gomi, K; Kobayashi, E; Nagamura, S; Okabe, M; Okamoto, A; Saito, H | 1 |
2 other study(ies) available for duocarmycin b2 and Experimental Neoplasms
| Article | Year |
|---|---|
Synthesis and antitumor activity of duocarmycin derivatives: modification of segment A of duocarmycin B2.
Topics: Animals; Antibiotics, Antineoplastic; Drug Screening Assays, Antitumor; Duocarmycins; HeLa Cells; Humans; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Pyrrolidinones; Sarcoma 180; Structure-Activity Relationship | 1996 |
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing beta-(5',6',7'-trimethoxy-2'-indolyl)acryloyl group.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Duocarmycins; HeLa Cells; Humans; Indoles; Inhibitory Concentration 50; Leukocyte Count; Male; Mice; Neoplasms, Experimental; Platelet Count; Pyrroles; Pyrrolidinones; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |